Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias-Reference-Cited by-同舟云学术

Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias

Published:2006-07-20 Issue:9 Volume:20 Page:1572-1581
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Malempati S,Tibbitts D,Cunningham M,Akkari Y,Olson S,Fan G,Sears R C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404317.pdf

Reference44 articles.

1. Cole MD . The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 1986; 20: 361–384.

2. Prochownik EV, Kukowska J . Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 1986; 322: 848–850.

3. Spotts GD, Hann SR . Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol Cell Biol 1990; 10: 3952–3964.

4. Nguyen HQ, Selvakumaran M, Liebermann DA, Hoffman B . Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells. Oncogene 1995; 11: 2439–2444.

5. Pelengaris S, Khan M, Evan G . c-MYC: more than just a matter of life and death suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Nat Rev Cancer 2002; 2: 764–776.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcineurin-mediated dephosphorylation enhances the stability and transactivation of c-Myc;Scientific Reports;2023-08-12

2. A New View of Activating Mutations in Cancer;Cancer Research;2022-09-07

3. Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma;Oncology Reports;2022-07-08

4. Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability;Cell Communication and Signaling;2022-05-26

5. Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma;Hematological Oncology;2022-05-05